The Global Blood Dialyzer Market
, by Product Type (Reusable and Disposable), by Dialysis Membrane Material (Cellulose Membranes and Synthetic Membranes), by End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Specialty Clinics),
was valued at US$ 4,682.7 million
in 2017, and is projected to exhibit a CAGR of 6.1%,
during the forecast period (2018 - 2026) as highlighted in a new report published by .
Dialysis is a treatment done on patients at later stage of kidney failure (chronic renal insufficiency). This treatment is achieved by using an assembly called dialyzers, which cleans blood and removes wastes and excess fluid from the body that are normally removed by healthy kidneys. In hemodialysis, blood is removed from the body and circulated through an extracorporeal fluid circuit (outside the body), then returned to the body. Hemodialyzer encloses a selectively permeable membrane acting as a filter that allows fluids and waste materials to pass through.
Increasing incidence of chronic kidney diseases is expected to increase the number of dialysis process, which in turn will fuel growth of the blood dialyzers market during the forecast period. For instance, according to the Global Kidney Health Atlas April 2017, one in three people in the general population is at increased risk of chronic kidney diseases and an estimated 10% of people worldwide, had chronic kidney disease (CKD) in 2017. Furthermore, the estimates suggest that 9 in 10 of those suffering from CKD are unacquainted of their condition.
Browse 23 Market Data Tables and 19 Figures spread through 157 Pages and in-depth TOC on "Blood Dialyzer Market, by Product Type (Reusable, and Disposable), by Dialysis Membrane Material (Cellulose Membranes, and Synthetic Membranes), by End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Specialty Clinics) - Global Forecast to 2026"
To know the latest trends and insights related to blood dialyzer market, click the link below:
Manufacturers are engaged in intensifying its services by expanding manufacturing units, and joint ventures. For instance, in December 2017, Nikkiso Co. Ltd. of Japan partnered with China based, Shandong Weigao Group Medical Polymer Company, to increase production of dialyzers in China by fivefold by 2020, and raise its output to 20,000 units every year.
Furthermore, key players are focusing on new product launches to maximize access to end users for its products and in turn increase its market share. For instance, in September 2016, B. Braun Medical Inc., launched xevonta kidney dialyzer, following 501(k) clearance by the FDA. This dialyzer will be available in the U.S. market. Xevonta kidney dialyzer's innovative membrane technology was intended to improve clearance performance by removing more toxins from patients’ blood. Also, in May 2017, NxStage Medical, Inc. received clearance from FDA for the next generation hemodialysis system. It consists of new features and capabilities, including a touchscreen user interface and integrated blood pressure monitor designed to enhance ease of use for patients to perform home hemodialysis.
Moreover, rising government initiatives to advance improved treatment options for patients with kidney failure aids manufacturers to gain substantial growth in the global blood dialyzer market. For instance, in September 2018, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) held a prize money of US $ 2,265,000 for KidneyX: Redesign Dialysis. This competition challenges manufacturers to develop better treatment options for patients with kidney failure. Thus, HHS is expecting innovations in the field of dialysis and dialyzer membranes to redesign treatment for kidney failure.
Key Takeaways of the Blood Dialyzer Market:
- The global blood dialyzer market is expected to expand at a CAGR of 6.1% during the forecast period (2018 – 2026), owing to continuous technological advancements in dialyzers membrane.
- Based on product type, disposable dialyzers are expected to receive maximum growth, owing to risks associated with reusable dialyzers.
- On the basis of dialysis membrane material, synthetic cellulose segment is expected to perceive maximum traction owing to new product launches. For instance, in November 2017, Nipro Medical Corporation announced the launch of Cellentia-H cellulose triacetate (CTA), a single-use dialyzer at the 2017 ASN Kidney Week Conference. The cellulose triacetate membrane optimizes excellent biocompatibility and clearances to minimize potential adverse reactions. The Cellentia-H is also gamma sterilized to enhance product safety and sterility. Such technology advancements in blood dialyzers promote its growth in the global market during the forecast period.
- Major players operating in the global blood dialyzer market include Baxter International, Inc., Nikkiso Co. Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., Diaverum Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Healthcare Partners, Inc.